Zhengye Biotechnology Holding (ZYBT) Notes Payables (2023 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Zhengye Biotechnology Holding (ZYBT) has disclosed Notes Payables for 2 consecutive years, with $10.4 million as the latest value for Q4 2024.

• Quarterly Notes Payables fell 6.56% to $10.4 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $10.4 million through Dec 2024, down 6.56% year-over-year, with the annual reading at $10.2 million for FY2024, 9.75% down from the prior year.
• Notes Payables for Q4 2024 was $10.4 million at Zhengye Biotechnology Holding, down from $11.1 million in the prior quarter.
• The five-year high for Notes Payables was $11.1 million in Q4 2023, with the low at $10.4 million in Q4 2024.

Peer Comparison